Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombosis 1Neoplasms 1Metabolic Diseases 1Hematologic Neoplasms 1Catheter-Related Infections 1Bacteremia 1Anemia, Aplastic 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Heparin × Clear all
NCT01820962 2013-03-29

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Maastricht University Medical Center

Phase 3 Terminated
212 enrolled
Other hematologic neoplasm

Thrombosis, Bacteremia, Hematologic Neoplasms, Catheter-Related Infections

NCT01343680 2012-05-30

Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology Patients

Alberta Children's Hospital

Phase 3 Terminated
2 enrolled
Classical hematology

Anemia, Aplastic, Metabolic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡